​

Traws Pharma Ownership | Who Owns Traws Pharma?

OverviewForecastRevenueFinancialsChart

Traws Pharma Ownership Summary

Traws Pharma is owned by 8.17% institutional investors, and 91.83% retail investors. Two sigma advisers, lp is the largest institutional shareholder, holding 0% of ONTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.45% of its assets in Traws Pharma shares.

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Two sigma advisers, lp---
Two sigma investments, lp---
Citadel advisors---
Wells fargo & company/mn---
Fmr---
Old point trust & financial services n a---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Two sigma advisers, lp---
Two sigma investments, lp---
Citadel advisors---
Wells fargo & company/mn---
Fmr---
Old point trust & financial services n a---

Top Buyers

HolderShares% AssetsChange
Wells fargo & company/mn---164.00
Old point trust & financial services n a---166.00
Fmr---1.00K
Citadel advisors---2.60K
Two sigma investments, lp---37.99K

Top Sellers

HolderShares% AssetsChange
Two sigma advisers, lp---73.07K
Two sigma investments, lp---37.99K
Citadel advisors---2.60K
Fmr---1.00K
Old point trust & financial services n a---166.00

Sold Out

HolderChange
Wells fargo & company/mn-164.00
Old point trust & financial services n a-166.00
Fmr-1.00K
Citadel advisors-2.60K
Two sigma investments, lp-37.99K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2024254.17%1,713,9132.75%812.95%8-620.00%
Dec 31, 202324-7.69%1,668,027-6.39%711.01%8-11.11%5-
Sep 30, 20232613.04%1,781,920-4.00%810.83%9-18.18%5150.00%
Jun 30, 202323-1,856,15730.15%819.13%1183.33%2-71.43%
Mar 31, 202323-11.54%1,426,208-8.10%612.35%6-45.45%7-12.50%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv365.66K1.45%-
Vanguard Institutional Extnd Mkt Idx Tr321.97K1.27%-
Fidelity Extended Market Index103.46K0.41%-938.00
BlackRock Extended Mkt Composite48.40K0.19%-
BlackRock Extended Equity Market K42.24K0.17%15.00
Fidelity Nasdaq Composite Index33.20K0.13%-
Fidelity Total Market Index23.17K0.09%-
Fidelity Series Total Market Index21.11K0.08%-
NT Ext Equity Mkt Idx Fd - NL16.82K0.07%-
Vanguard Instl Ttl Stck Mkt Idx Tr14.44K0.06%-

Recent Insider Transactions

DateNameRoleActivityValue
Jan 28, 2022OLER ABRAHAM N. SVP Corp Dev & Gen CounselBuy$2.50K
Jan 21, 2022OLER ABRAHAM N. SVP Corp Dev & Gen CounselBuy$3.03K
Jan 14, 2022OLER ABRAHAM N. SVP CORP DEV & GEN COUNSELBuy$3.30K
Jan 07, 2022OLER ABRAHAM N. SVP Corp Dev & Gen CounselBuy$3.58K
Nov 19, 2021OLER ABRAHAM N. SVP CORP DEV & GEN COUNSELBuy$3.16K

Insider Transactions Trends

DateBuySell
2024 Q1--
2023 Q4--
2023 Q3--
2023 Q2--
2023 Q1--

ONTX Ownership FAQ

Who owns the most shares of Traws Pharma?

Traws Pharma’s largest shareholders are Two sigma advisers, lp (0 shares, 0%), Two sigma investments, lp (0 shares, 0%), and Citadel advisors (0 shares, 0%). Together, they hold 0% of Traws Pharma’s total shares outstanding.

Does Blackrock own Traws Pharma?

BlackRock is not among the top 10 institutional shareholders of Traws Pharma.

Who is Traws Pharma’s biggest shareholder by percentage of total assets invested?

Two sigma advisers, lp is Traws Pharma’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Traws Pharma shares, valued at 0$.

Who is the top mutual fund holder of Traws Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Traws Pharma shares, with 1.45% of its total shares outstanding invested in 365.66K Traws Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools